COVID-19 News Updates

Following a continuous downward trend, India's active caseload has declined to 11,058. Active cases now constitute 0.03 per cent of the country's total positive cases.

Those above the age of 18 years and who have completed nine months of their second dose of vaccine are eligible for the third dose

The US continues to be the worst-hit country with the world's highest number of cases and deaths at 80,399,474 and 985,482 respectively

The daily positivity rate was recorded at 0.25 per cent and the weekly positivity rate was 0.23 per cent

BIG Cut In Covid19 Vaccine Prices Announced

Covaxin will now cost Rs 225 per dose at private hospitals, from Rs 1,200 earlier.

According to a recent peer-reviewed study published by the University of Florida group, like PCR tests, the device is 90 per cent accurate, with the same sensitivity.

Serum Institute of India CEO Adar Poonawalla said that SII has decided to revise the price of Covishield vaccine for private hospitals after discussions with the Central government.

Service charge for booster dose at private vaccination centres has been capped at Rs150, announced the Union Health Ministry on Saturday

XE, the latest mutant of Omicron may be more transmissible than the previous ones, the World Health Organization has said.

While the daily positivity rate was recorded at 0.25 per cent, the weekly positivity rate was at 0.23 per cent, according to the health ministry.

A new strain of the COVID-19 Omicron variant, first detected in the United Kingdom, appears to be more transmissible than previous strains of the virus, the World Health Organization (WHO) had said.

The administration of precaution dose to those above the age of 18 years will be through private vaccination centres and the drive would start from April 10, 2022.

The daily positivity rate was recorded at 0.24 per cent and the weekly positivity rate was 0.23 per cent, according to the health ministry.

As per World Health Organisation (WHO), XE variant of Covid-19 is 10 per cent more infectious than other sub-variants of Omicron-- BA.1 and BA.2